Axogen

$19.43
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.02 (+5.54%) Today

$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Axogen and other stocks, options, and ETFs commission-free!

About AXGN

AxoGen, Inc. engages in the development and market of surgical solutions for peripheral nerves. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. Its products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL. The listed name for AXGN is Axogen, Inc. Common Stock.

CEO

Karen L. Zaderej

Employees

394

Headquarters

Alachua, Florida

Founded

1977

Market Cap

789.22M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

296.66K

High Today

$19.62

Low Today

$18.35

Open Price

$18.50

Volume

381.47K

52 Week High

$20.83

52 Week Low

$7.16

Collections

Analyst Ratings

71%

of 7 ratings

Buy

71%

Hold

29%

Sell

AXGN Earnings

-$0.38

-$0.24

-$0.10

$0.04

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Feb 22, After Hours